549
Views
6
CrossRef citations to date
0
Altmetric
Scientific Articles

The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats

, , &
Pages 208-213 | Received 23 Apr 2013, Accepted 14 Nov 2013, Published online: 28 Feb 2014

References

  • *Anonymous. European Agency for the Evaluation of Medicinal Products. Guideline on the investigation of bioequivalence. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf (accessed August 15, 2013). European Medicines Agency, London, UK 2010
  • Ciribassi J, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, Kaloostian-Whittymore L. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. American Journal of Veterinary Research 64, 994–8, 2003 doi: 10.2460/ajvr.2003.64.994
  • Edinboro CH, Scott-Moncrieff JC, Janovitz E, Thacker HL, Glickman LT. Epidemiologic study of relationships between consumption of commercial canned food and risk of hyperthyroidism in cats. Journal of the American Veterinary Medical Association 224, 879–86, 2004 doi: 10.2460/javma.2004.224.879
  • Frenais R, Burgaud S, Horspool LJI. Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats. Journal of Veterinary Pharmacology and Therapeutics 31, 213–9, 2008 doi: 10.1111/j.1365-2885.2008.00949.x
  • Frenais R, Rosenberg D, Burgaud S, Horspool LJI. Clinical efficacy and safety of a once-daily formulation of carbimazole in cats with hyperthyroidism. Journal of Small Animal Practice 50, 510–5, 2009 doi: 10.1111/j.1748-5827.2009.00772.x
  • Hill KE, Gieseg MA, Kingsbury D, Lopez-Villalobos N, Bridges J, Chambers P. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. Journal of Veterinary Internal Medicine 25, 1357–65, 2011 doi: 10.1111/j.1939-1676.2011.00799.x
  • Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. Journal of Veterinary Pharmacology and Therapeutics 25, 189–93, 2002 doi: 10.1046/j.1365-2885.2002.00405.x
  • Hoffmann G, Marks SL, Taboada J, Hosgood GL, Wolfsheimer KJ. Transdermal methimazole treatment in cats with hyperthyroidism. Journal of Feline Medicine and Surgery 5, 77–82, 2003 doi: 10.1016/S1098-612X(02)00095-5
  • Jansson R, Dahlberg PA, Lindstrom B. Comparative Bioavailability of Carbimazole and Methimazole. International Journal of Clinical Pharmacology and Therapeutics 21, 505–10, 1983
  • Lecuyer M, Prini S, Dunn ME, Douce MY. Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Canadian Veterinary Journal-Revue Veterinaire Canadienne 47, 131–5, 2006
  • MacGregor JM, Rush JE, Rozanski EA, Boothe DM, Belmonte AA, Freeman LM. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats. American Journal of Veterinary Research 69, 39–44, 2008 doi: 10.2460/ajvr.69.1.39
  • Mealey KL, Peck KE, Bennett BS, Sellon RK, Swinney GR, Melzer K, Gokhale SA, Krone T. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. Journal of Veterinary Internal Medicine 18, 43–6, 2004 doi: 10.1111/j.1939-1676.2004.tb00133.x
  • Mills PC, Cross SE. Transdermal drug delivery: Basic principles for the veterinarian. Veterinary Journal 172, 218–33, 2006 doi: 10.1016/j.tvjl.2005.09.006
  • Mills PC, Magnusson BM, Cross SE. Investigation of in vitro transdermal absorption of fentanyl from patches placed on skin samples obtained from various anatomic regions of dogs. American Journal of Veterinary Research 65, 1697–700, 2004 doi: 10.2460/ajvr.2004.65.1697
  • Mills PC, Magnusson BM, Cross SE. Effects of vehicle and region of application on absorption of hydrocortisone through canine skin. American Journal of Veterinary Research 66, 43–7, 2005 doi: 10.2460/ajvr.2005.66.43
  • Mills PC, Magnusson BM, Cross SE. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin. Veterinary Journal 171, 276–80, 2006 doi: 10.1016/j.tvjl.2004.11.013
  • Mooney CT. Pathogenesis of feline hyperthyroidism. Journal of Feline Medicine and Surgery 4, 167–9, 2002 doi: 10.1053/jfms.2002.0177
  • Mooney CT, Thoday KL, Doxey DL. Carbimazole therapy of feline hyperthyroidism. Journal of Small Animal Practice 33, 228–35, 1992 doi: 10.1111/j.1748-5827.1992.tb01122.x
  • Peterson ME. Feline hyperthyroidism. Veterinary Clinics of North America-Small Animal Practice 14, 809–26, 1984
  • Peterson ME. Radioiodine treatment of hyperthyroidism. Clinical Techniques in Small Animal Practice 21, 34–9, 2006 doi: 10.1053/j.ctsap.2005.12.006
  • Peterson ME, Kintzer PP, Hurvitz AI. Methimazole treatment of 262 cats with hyperthyroidism. Journal of Veterinary Internal Medicine 2, 150–7, 1988 doi: 10.1111/j.1939-1676.1988.tb02812.x
  • Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Advanced Drug Delivery Reviews 50, 175–203, 2001 doi: 10.1016/S0169-409X(01)00157-0
  • Rutland BE, Nachreiner RF, Kruger JM. Optimal testing for thyroid hormone concentration after treatment with methimazole in healthy and hyperthyroid cats. Journal of Veterinary Internal Medicine 23, 1025–30, 2009 doi: 10.1111/j.1939-1676.2009.0370.x
  • Sartor LL, Trepanier LA, Kroll MM, Rodan I, Challoner L. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. Journal of Veterinary Internal Medicine 18, 651–5, 2004 doi: 10.1111/j.1939-1676.2004.tb02601.x
  • Scarlett JM. Epidemiology of thyroid-diseases of dogs and cats. Veterinary Clinics of North America-Small Animal Practice 24, 477–86, 1994
  • Toutain PL, Bousquet-Melou A. Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics 27, 427–39, 2004 doi: 10.1111/j.1365-2885.2004.00600.x
  • Toutain PL, Modric S, Bousquet-Melou A, Sallovitz JM, Lanusse C. Should licking behavior be considered in the bioavailability evaluation of transdermal products? Journal of Veterinary Pharmacology and Therapeutics 35, 39–43, 2012 doi: 10.1111/j.1365-2885.2012.01380.x
  • Trepanier LA. Pharmacologic management of feline hyperthyroidism. Veterinary Clinics of North America-Small Animal Practice 37, 775–88, 2007 doi: 10.1016/j.cvsm.2007.03.004
  • Trepanier LA, Peterson ME, Aucoin DP. Pharmacokinetics of methimazole in normal cats and cats with hyperthyroidism. Research in Veterinary Science 50, 69–74, 1991a doi: 10.1016/0034-5288(91)90055-S
  • Trepanier LA, Peterson ME, Aucoin DP. Pharmacokinetics of intravenous and oral methimazole following single-dose and multiple-dose administration in normal cats. Journal of Veterinary Pharmacology and Therapeutics 14, 367–73, 1991b doi: 10.1111/j.1365-2885.1991.tb00850.x
  • Weiss M, Milman B, Rosen B, Zimlichman R. Quantitation of thyroid-hormone effect on skin perfusion by laser doppler flowmetry. Journal of Clinical Endocrinology & Metabolism 76, 680–2, 1993
  • Wells SM, Glerum LE, Papich MG. Pharmacokinetics of butorphanol in cats after intramuscular and buccal transmucosal administration. American Journal of Veterinary Research 69, 1548–54, 2008 doi: 10.2460/ajvr.69.12.1548

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.